// App-Quantinova.ai

BSH19‐OR‐018 : Ixazomib plus Lenalidomide‐Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Pooled Analysis from the INSIGHT MM Observational Study and the Czech Registry of Monoclonal Gammopathies

Researchers

Presenter

  • G. Cook

Principal Investigators

  • E. Terpos

  • H.C. Lee

  • A. Chari

  • C.L. Costello

  • N. Puig

  • X. Leleu

  • J.G. Berdeja

  • F.E. Davies

  • K.C. Weisel

  • S.Z. Usmani

  • V.T.M. Hungria

  • M. Boccadoro

  • R.M. Rifkin

  • J.A. Zonder

  • L. Broov

  • M. Barinov

  • K. Ren

  • R. Cacioppo

  • T. Skacel

  • D.M. Stull

  • V. Maisnar

Medical Centers

  • Haematology, Clinical Trials Research Unit, NIHR (Leeds) IVD Cooperative, Leeds Teaching Hospital, Leeds, United Kingdom

  • Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Urology, Mount Sinai School of Medicine, New York, NY

  • Division of Blood and Marrow Transplant, Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States

  • hematology Division, Hospital Universitaro de Salamanca, Salamanca, Spain

  • Pôle Régional de Cancérologie, CHU de Poitiers, Poitiers, France

  • Department of Hematology, Sarah Cannon Research Institute, Nashville, TN

  • Myeloma Institute for Research and Therapy, Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), Little Rock, AR

  • Dept. Internal Medicine II, University Hospital, Tuebingen, Germany

  • Department of Hematologic Oncology and Blood Disorders,Levine Cancer Institute, Atrium Health,Charlotte,Vereinigte Staaten

  • Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil

  • Division of Cardiology, Citt- della Salute e della Scienza di Torino, University of Turin, Turin, Italy

  • Hematology Research, US Oncology Research, Rocky Mountain Cancer Centers, Yampa Valley Medical Center, United States, Texas

  • Department of Malignant Hematology, Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI

  • Institute of Biostatistics and Analyses, Brno, Czech Republic

  • Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Deerfield, IL

  • Fourth Department of Medicine ‐ Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic

Locations

  • United Kingdom

  • Czech Republic

  • Greece

  • United States

  • Spain

  • France

  • Germany

  • Brazil

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Intratect

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • carfilzomib Intravenous

  • daratumumab Intravenous

  • Thalidomide

  • Bortezomib

  • Ixazomib

  • Techniclone TNT

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • NCT02761187

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved